Keros Therapeutics Inc (KROS)

Dec 09, 2025

Myelofibrosis Market to Expand Significantly by 2034, States DelveInsight Report | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros Therapeutics - Barchart.com

Dec 09, 2025

Dec 06, 2025

Would You Still Hold Keros Therapeutics Stock If It Fell 30%? - Trefis

Dec 06, 2025

Dec 05, 2025

Can Keros Therapeutics Stock Hold Up When Markets Turn? - Trefis

Dec 05, 2025

Dec 05, 2025

Keros Therapeutics (NASDAQ:KROS) Trading Up 12%Here's Why - MarketBeat

Dec 05, 2025

Dec 05, 2025

There's No Escaping Keros Therapeutics, Inc.'s (NASDAQ:KROS) Muted Revenues Despite A 30% Share Price Rise - 富途牛牛

Dec 05, 2025

Dec 05, 2025

How Keros Therapeutics Inc. stock benefits from tech adoptionWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - Newser

Dec 05, 2025

Dec 05, 2025

Franklin Resources Inc. Grows Stake in Keros Therapeutics, Inc. $KROS - Defense World

Dec 05, 2025

Dec 04, 2025

Will Keros Therapeutics Inc. stock outperform growth indexesBull Run & Fast Momentum Entry Tips - Newser

Dec 04, 2025

Dec 04, 2025

Top investors say Keros Therapeutics Inc (KROS) ticks everything they need - Setenews

Dec 04, 2025

Dec 03, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Dec 03, 2025

Dec 01, 2025

Understanding the Setup: (KROS) and Scalable Risk - news.stocktradersdaily.com

Dec 01, 2025

Nov 30, 2025

TD Cowen Downgrades Keros Therapeutics (KROS) - MSN

Nov 30, 2025

Nov 29, 2025

Keros Therapeutics (KROS) Gets a Hold from Bank of America Securities - The Globe and Mail

Nov 29, 2025

Nov 29, 2025

Bank of America Increases Keros Therapeutics (NASDAQ:KROS) Price Target to $19.00 - MarketBeat

Nov 29, 2025

Nov 29, 2025

Keros Therapeutics (NASDAQ:KROS) Price Target Raised to $19.00 at Bank of America - Defense World

Nov 29, 2025

Nov 28, 2025

B of A Securities Maintains Keros Therapeutics (KROS) Neutral Recommendation - Nasdaq

Nov 28, 2025

Nov 28, 2025

How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24% - MSN

Nov 28, 2025

Nov 27, 2025

KROS or NVZMY: Which Is the Better Value Stock Right Now? - MSN

Nov 27, 2025

Nov 24, 2025

ExodusPoint Capital Management, LP's Strategic Acquisition of Ke - GuruFocus

Nov 24, 2025

Nov 23, 2025

Keros Therapeutics Reports Strong Revenue Growth - MSN

Nov 23, 2025

Nov 21, 2025

Keros Therapeutics Announces Final Results of Tender Offer - The Manila Times

Nov 21, 2025

Nov 20, 2025

Latham & Watkins Advises on Keros Therapeutics, Inc.’s US$194.4 Million Tender Offer - Latham & Watkins LLP

Nov 20, 2025

Nov 20, 2025

The Technical Signals Behind (KROS) That Institutions Follow - news.stocktradersdaily.com

Nov 20, 2025

Nov 20, 2025

Keros Therapeutics announces final results of tender offer - marketscreener.com

Nov 20, 2025

Nov 20, 2025

[SC TO-I/A] Keros Therapeutics, Inc. Amended Issuer Tender Offer | KROS SEC FilingForm SC TO-I/A - Stock Titan

Nov 20, 2025

Nov 20, 2025

Keros Therapeutics (NASDAQ:KROS) Shares Gap DownHere's Why - MarketBeat

Nov 20, 2025

Nov 20, 2025

Is Keros Therapeutics Inc. stock reversal real or fakeWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Keros Therapeutics reports oversubscribed $194.4 million tender offer By Investing.com - Investing.com Nigeria

Nov 19, 2025

Nov 19, 2025

Can Keros Therapeutics Inc. stock maintain operating margins2025 Technical Patterns & Fast Entry High Yield Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Keros to Repurchase 11 Million Shares in Oversubscribed Tender Offer - MarketScreener

Nov 19, 2025

Nov 19, 2025

Keros Therapeutics Reports Third Quarter 2025 Financial Results - Sahm

Nov 19, 2025

Nov 19, 2025

Keros Therapeutics reports oversubscribed $194.4 million tender offer - Investing.com

Nov 19, 2025

Nov 19, 2025

Keros Therapeutics Announces Preliminary Results of Tender Offer - The Manila Times

Nov 19, 2025

Nov 19, 2025

Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - MSN

Nov 19, 2025

Nov 18, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Held Back By Insufficient Growth Even After Shares Climb 26% - simplywall.st

Nov 18, 2025

Nov 18, 2025

How to manage a losing position in Keros Therapeutics Inc.Portfolio Value Report & Free Accurate Trade Setup Notifications - newser.com

Nov 18, 2025

Nov 17, 2025

Keros Therapeutics, Inc.'s Equity Buyback announced on October 20, 2025, has closed with 10,950,165 shares, representing 26.95% for $194.37 million. - marketscreener.com

Nov 17, 2025

Nov 16, 2025

How to recover losses in Keros Therapeutics Inc. stockJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com

Nov 16, 2025

Nov 16, 2025

Los Angeles Capital Management LLC Purchases New Stake in Keros Therapeutics, Inc. $KROS - MarketBeat

Nov 16, 2025

Nov 16, 2025

Is Keros Therapeutics Inc. stock attractive for income investors2025 Buyback Activity & Reliable Entry Point Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Keros Therapeutics, Inc. $KROS - MarketBeat

Nov 16, 2025

Nov 15, 2025

Will Keros Therapeutics Inc. stock rally after Fed decisionsWeekly Profit Summary & Daily Chart Pattern Signals - newser.com

Nov 15, 2025

Nov 15, 2025

Can trapped investors hope for a rebound in Keros Therapeutics Inc.2025 Volatility Report & Safe Entry Momentum Tips - newser.com

Nov 15, 2025

Nov 15, 2025

Keros Therapeutics Stock Plunges 81% in 3 Months: Here's Why - MSN

Nov 15, 2025

Nov 15, 2025

Will Keros Therapeutics Inc. price bounce be sustainable2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com

Nov 15, 2025